Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process

I. Wolf; B. Waissengrin; A. Zer; R. Bernstein-Molho; K. Rouvinov; J. E. Cohen; N. I. Cherny; G. Bar-Sela

doi:10.1016/j.esmoop.2021.100379

Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process

I. Wolf, B. Waissengrin, A. Zer, R. Bernstein-Molho, K. Rouvinov, J. E. Cohen, N. I. Cherny, G. Bar-Sela

Oncology

Research output: Contribution to journal › Editorial

3 Scopus citations

Original language	English
Article number	100379
Journal	ESMO Open
Volume	7
Issue number	1
DOIs	https://doi.org/10.1016/j.esmoop.2021.100379
State	Published - Feb 2022

Funding

Funders	Funder number
Israeli Society for Clinical Oncology and Radiotherapy
Israeli Society of Clinical Oncology
Medison Pharma
Monsa Fund
Pfizer
AstraZeneca
Novartis
Roche
Meso Scale Diagnostics
Takeda Pharmaceutical Company
Israel Cancer Association
Israel Science Foundation

Access to Document

10.1016/j.esmoop.2021.100379

Cite this

@article{0dea511fe14c434fb124a3b063dc7832,

title = "Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process",

author = "I. Wolf and B. Waissengrin and A. Zer and R. Bernstein-Molho and K. Rouvinov and Cohen, {J. E.} and Cherny, {N. I.} and G. Bar-Sela",

note = "Funding Information: IW declares grants or contracts from any entity: Merck Sharp & Dohme (MSD), Novartis, Roche, Beyond Air. Consulting fees: Bristol Myers Squibb (BMS), Beyond Air, Roche. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: Roche, BMS, Novartis, MSD, AstraZeneca. Participation on a Data Safety Monitoring Board or Advisory Board: MSD, AstraZeneca. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Israeli Cancer Association. Stock or stock options: Breath of Life. BW declares consulting fees: MSD. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: MSD, BMS, AstraZeneca, Roche, Merck. AZ declares payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS. Consulting fees: Roche, MSD, AstraZeneca, Novartis, Steba. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: Takeda, Roche, AstraZeneca. Support for attending meetings and/or travel: AstraZeneca, MSD, Roche. Participation on a Data Safety Monitoring Board or Advisory Board: AstraZeneca, Novartis. Stock or stock options: Nixio. RK declares consulting fees: Jonson, AstraZeneca. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, MSD, Medison. Support for attending meetings and/or travel: Pfizer, Medison. GBS declares consulting fees: Novartis, Merck, Dexcel, Teva. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, MSD, Merck, Novartis, Dexcel, Medison, Sanofi, Roch, Rafa. Participation on a Data Safety Monitoring Board or Advisory Board: Abbott. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Chairman of the Israeli Society of Clinical Oncology & Radiation therapy. JEC declares grants or contracts from any entity: Israel Precision Medicine Program, Israel Science Foundation, Monsa Fund. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, Roche, Medison Pharma, MSD, Sanofi, Novartis. Support for attending meetings and/or travel: BMS, Medison Pharma, MSD, Roche. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid. Member, advisory committee for drug and technology inclusion in the national basket of services, Israeli Society for Clinical Oncology and Radiotherapy (ISCORT). NIC declares—stock or stock options: Expain. RBM has declared no conflicts of interest. Funding Information: None declared. IW declares grants or contracts from any entity: Merck Sharp & Dohme (MSD), Novartis, Roche, Beyond Air. Consulting fees: Bristol Myers Squibb (BMS), Beyond Air, Roche. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: Roche, BMS, Novartis, MSD, AstraZeneca. Participation on a Data Safety Monitoring Board or Advisory Board: MSD, AstraZeneca. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Israeli Cancer Association. Stock or stock options: Breath of Life. BW declares consulting fees: MSD. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: MSD, BMS, AstraZeneca, Roche, Merck. AZ declares payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS. Consulting fees: Roche, MSD, AstraZeneca, Novartis, Steba. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: Takeda, Roche, AstraZeneca. Support for attending meetings and/or travel: AstraZeneca, MSD, Roche. Participation on a Data Safety Monitoring Board or Advisory Board: AstraZeneca, Novartis. Stock or stock options: Nixio. RK declares consulting fees: Jonson, AstraZeneca. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, MSD, Medison. Support for attending meetings and/or travel: Pfizer, Medison. GBS declares consulting fees: Novartis, Merck, Dexcel, Teva. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, MSD, Merck, Novartis, Dexcel, Medison, Sanofi, Roch, Rafa. Participation on a Data Safety Monitoring Board or Advisory Board: Abbott. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Chairman of the Israeli Society of Clinical Oncology & Radiation therapy. JEC declares grants or contracts from any entity: Israel Precision Medicine Program, Israel Science Foundation, Monsa Fund. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, Roche, Medison Pharma, MSD, Sanofi, Novartis. Support for attending meetings and/or travel: BMS, Medison Pharma, MSD, Roche. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid. Member, advisory committee for drug and technology inclusion in the national basket of services, Israeli Society for Clinical Oncology and Radiotherapy (ISCORT). NIC declares—stock or stock options: Expain. RBM has declared no conflicts of interest.",

year = "2022",

month = feb,

doi = "10.1016/j.esmoop.2021.100379",

language = "אנגלית",

volume = "7",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Implementation of the ESMO-Magnitude of Clinical Benefit Scale

T2 - real world example from the 2022 Israeli National Reimbursement Process

AU - Wolf, I.

AU - Waissengrin, B.

AU - Zer, A.

AU - Bernstein-Molho, R.

AU - Rouvinov, K.

AU - Cohen, J. E.

AU - Cherny, N. I.

AU - Bar-Sela, G.

N1 - Funding Information: IW declares grants or contracts from any entity: Merck Sharp & Dohme (MSD), Novartis, Roche, Beyond Air. Consulting fees: Bristol Myers Squibb (BMS), Beyond Air, Roche. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: Roche, BMS, Novartis, MSD, AstraZeneca. Participation on a Data Safety Monitoring Board or Advisory Board: MSD, AstraZeneca. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Israeli Cancer Association. Stock or stock options: Breath of Life. BW declares consulting fees: MSD. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: MSD, BMS, AstraZeneca, Roche, Merck. AZ declares payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS. Consulting fees: Roche, MSD, AstraZeneca, Novartis, Steba. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: Takeda, Roche, AstraZeneca. Support for attending meetings and/or travel: AstraZeneca, MSD, Roche. Participation on a Data Safety Monitoring Board or Advisory Board: AstraZeneca, Novartis. Stock or stock options: Nixio. RK declares consulting fees: Jonson, AstraZeneca. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, MSD, Medison. Support for attending meetings and/or travel: Pfizer, Medison. GBS declares consulting fees: Novartis, Merck, Dexcel, Teva. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, MSD, Merck, Novartis, Dexcel, Medison, Sanofi, Roch, Rafa. Participation on a Data Safety Monitoring Board or Advisory Board: Abbott. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Chairman of the Israeli Society of Clinical Oncology & Radiation therapy. JEC declares grants or contracts from any entity: Israel Precision Medicine Program, Israel Science Foundation, Monsa Fund. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, Roche, Medison Pharma, MSD, Sanofi, Novartis. Support for attending meetings and/or travel: BMS, Medison Pharma, MSD, Roche. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid. Member, advisory committee for drug and technology inclusion in the national basket of services, Israeli Society for Clinical Oncology and Radiotherapy (ISCORT). NIC declares—stock or stock options: Expain. RBM has declared no conflicts of interest. Funding Information: None declared. IW declares grants or contracts from any entity: Merck Sharp & Dohme (MSD), Novartis, Roche, Beyond Air. Consulting fees: Bristol Myers Squibb (BMS), Beyond Air, Roche. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: Roche, BMS, Novartis, MSD, AstraZeneca. Participation on a Data Safety Monitoring Board or Advisory Board: MSD, AstraZeneca. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Israeli Cancer Association. Stock or stock options: Breath of Life. BW declares consulting fees: MSD. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: MSD, BMS, AstraZeneca, Roche, Merck. AZ declares payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS. Consulting fees: Roche, MSD, AstraZeneca, Novartis, Steba. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: Takeda, Roche, AstraZeneca. Support for attending meetings and/or travel: AstraZeneca, MSD, Roche. Participation on a Data Safety Monitoring Board or Advisory Board: AstraZeneca, Novartis. Stock or stock options: Nixio. RK declares consulting fees: Jonson, AstraZeneca. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, MSD, Medison. Support for attending meetings and/or travel: Pfizer, Medison. GBS declares consulting fees: Novartis, Merck, Dexcel, Teva. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, MSD, Merck, Novartis, Dexcel, Medison, Sanofi, Roch, Rafa. Participation on a Data Safety Monitoring Board or Advisory Board: Abbott. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Chairman of the Israeli Society of Clinical Oncology & Radiation therapy. JEC declares grants or contracts from any entity: Israel Precision Medicine Program, Israel Science Foundation, Monsa Fund. Payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing or educational events: BMS, Roche, Medison Pharma, MSD, Sanofi, Novartis. Support for attending meetings and/or travel: BMS, Medison Pharma, MSD, Roche. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid. Member, advisory committee for drug and technology inclusion in the national basket of services, Israeli Society for Clinical Oncology and Radiotherapy (ISCORT). NIC declares—stock or stock options: Expain. RBM has declared no conflicts of interest.

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85123844810&partnerID=8YFLogxK

U2 - 10.1016/j.esmoop.2021.100379

DO - 10.1016/j.esmoop.2021.100379

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 35121523

AN - SCOPUS:85123844810

SN - 2059-7029

VL - 7

JO - ESMO Open

JF - ESMO Open

IS - 1

M1 - 100379

ER -

Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process

Funding

Access to Document

Other files and links

Cite this